Position in REPL
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,938,883
-$154,123 QoQ
Shares Held
253,449
+17.7% QoQ
Ownership
0.302%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. REPL ranks #184 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in REPL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,938,883 | 253,449 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,093,006 | 215,330 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $457,899 | 109,284 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $4,692,462 | 505,109 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,522,450 | 361,277 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $295,762 | 24,423 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,193,631 | 108,908 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $762,066 | 84,674 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,186,551 | 390,031 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,860,052 | 220,647 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,150,229 | 125,671 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,398,927 | 103,313 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,003,395 | 283,318 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,515,863 | 92,495 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,231,954 | 71,335 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,092,900 | 62,523 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,232,390 | 72,579 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $574,086 | 21,184 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $256,325 | 8,648 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $356,037 | 9,267 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $457,130 | 14,983 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,857,665 | 153,543 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $3,095,499 | 134,470 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,009,463 | 282,071 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,427,576 | 444,090 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||